Skip to content
value.today

Moonwalk Biosciences, Inc.

Total raised
$110 M
2 rounds on record
Latest round
$60 M
Aug 2026
First round on record
Dec 2023
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Moonwalk Biosciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2026$60 MNo. 2$50 to $250 million

Moonwalk Biosciences, Inc.: Raise no. 2, Aug 2026

Investors in this round

7 investors had bought by the notice of Sep 14, 2026: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$60 M of $70 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander Aravanis · Executive Officer, Director
  • Arash Jamshidi · Executive Officer, Director
  • Elaine Cheung · Executive Officer
  • John Liles · Executive Officer
  • Justin Valley · Executive Officer
  • Stephen Djedjos · Executive Officer
  • Chris Dimitropoulos · Director
  • Paul Burton · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Arash Jamshidi, President. Newest notice filed Sep 14, 2026. Read the notice at the SEC.

equitySEC
Dec 2023$50 MNo. 1$10 to $50 million

Moonwalk Biosciences, Inc.: Raise no. 1, Dec 2023

Investors in this round

24 investors had bought by the notice of Jan 2, 2024: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$50 M of $57 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander Aravanis · Executive Officer, Director
  • Arash Jamshidi · Executive Officer, Director
  • Justin Keller Valley · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes $6,575,000 in debt cancelled convertible debt and does not include $400,000 sold to three investors residing outside of the United States.”

Signed by Arash Jamshidi, President. Newest notice filed Jan 2, 2024. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Moonwalk Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2026).

    SEC Form D · Sep 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Sep 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Moonwalk Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Moonwalk Biosciences, Inc.
NameRoleNamed in
Alexander AravanisExecutive officerSep 2026
Arash JamshidiExecutive officerSep 2026
Elaine CheungExecutive officerSep 2026
John LilesExecutive officerSep 2026
Justin ValleyExecutive officerSep 2026
Stephen DjedjosExecutive officerSep 2026
Justin Keller ValleyExecutive officerJan 2024
Alexander AravanisDirectorSep 2026
Arash JamshidiDirectorSep 2026
Chris DimitropoulosDirectorSep 2026
Paul BurtonDirectorSep 2026